K107375PAnti-C1orf56 Polyclonal Antibody
Anti-C1orf56 Polyclonal Antibody 應(yīng)用WB 稀釋比例WB 1:5000-8000. 交叉反應(yīng)Human
訪問(wèn)次數(shù):701 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107374PAnti-PCTK1 Polyclonal Antibody
Anti-PCTK1 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:50-200. 交叉反應(yīng)Human Mouse
訪問(wèn)次數(shù):586 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107373PAnti-GTPBP6 Polyclonal Antibody
Anti-GTPBP6 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-10000. IHC 1:25-100. 交叉反應(yīng)Human
訪問(wèn)次數(shù):603 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107372PAnti-NPRL3 Polyclonal Antibody
Anti-NPRL3 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human Mouse
訪問(wèn)次數(shù):633 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107371PAnti-GPI Polyclonal Antibody
Anti-GPI Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human
訪問(wèn)次數(shù):595 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107370PAnti-ENO1 Polyclonal Antibody
Anti-ENO1 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human Rat
訪問(wèn)次數(shù):615 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107369PAnti-CBX8 Polyclonal Antibody
Anti-CBX8 Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human
訪問(wèn)次數(shù):696 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107368PAnti-HOMER1 Polyclonal Antibody
Anti-HOMER1 Polyclonal Antibody 應(yīng)用WB 稀釋比例WB 1:5000-8000. 交叉反應(yīng)Human Mouse Rat
訪問(wèn)次數(shù):579 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107367PAnti-EIF3G Polyclonal Antibody
Anti-EIF3G Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:50-200. 交叉反應(yīng)Human Mouse
訪問(wèn)次數(shù):633 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107366PAnti-ATF1 Polyclonal Antibody
Anti-ATF1 Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human
訪問(wèn)次數(shù):684 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14